Noncompliance in the use of cardiovascular medications in the medicare part D population

Medicare and Medicaid Research Review

Volumn 1, Issue 4, 2011, Pages

  Blackwell, Steven A ^a   Baugh, David K ^a   Montgomery, Melissa A ^a   Ciborowski, Gary M ^a   Waldron, Charles J ^a   Riley, Gerald F ^a  

^a CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

Author keywords

Cardiovascular; Medicare; Noncompliance; Part D

Indexed keywords

ANTIANGINA PECTORIS AGENT; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOTONIC AGENT; DIURETIC AGENT; CARDIOVASCULAR AGENT;

AGE DISTRIBUTION; AGED; CROSS-SECTIONAL STUDY; ETHNICITY; FEMALE; HEALTH CARE COST; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PATIENT COMPLIANCE; PATIENT IDENTIFICATION; POPULATION; RACE; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SEX DIFFERENCE; AGE; ARTICLE; CARDIOVASCULAR DISEASE; COST OF ILLNESS; DRUG COST; ECONOMICS; FINANCIAL MANAGEMENT; MEDICATION COMPLIANCE; STATISTICS; UNITED STATES; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DRUG COSTS; FEMALE; FINANCING, PERSONAL; HUMANS; MALE; MEDICARE PART C; MEDICARE PART D; MEDICATION ADHERENCE; RETROSPECTIVE STUDIES; SEX FACTORS; UNITED STATES;

EID: 84930480775     PISSN: 21590354     EISSN: None     Source Type: Journal    
DOI: 10.5600/MMRR.001.04.A05     Document Type: Review

References (43)

1. Balbay, O., Annakkaya, A. N., Arbak, P., Bilgin, C., & Erbas, M. (2005). Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey. Japanese Journal of Infectious Diseases, 58, 152-158. PubMed
2. Benner, J. S., Glynn, R. J., Mogun, H., Neuman, P., Weinstein, M. C., & Avorn, J. (2002). Long-term persistence in use of statin therapy in elderly patients. Journal of the American Medical Association, 288, 455-461. PubMed doi:10.1001/jama.288.4.455
3. Billups, S. J., Malone, D. C., & Carter, B. L. (2000). Relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy, 20(8), 941-949. PubMed doi:10.1592/phco.20.11.941.35266
4. Christensen, D. B., Williams, B., Goldberg, H. I., Martin, D. P., Engelberg, R., & LoGerfo, J. P. (1997). Assessing compliance to antihypertensive medications using computer-based pharmacy records. Medical Care, 35, 1164-1170. PubMed doi:10.1097/00005650-199711000-00008
5. Col, N., Fanale, J. E., & Kronholm, P. (1990). The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Archives of Internal Medicine, 150, 841-845. PubMed doi:10.1001/archinte.150.4.841
6. Duncan, J. C., & Rogers, R. (1998). Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders. Journal of Forensic Sciences, 43, 1133-1137. PubMed
7. Gary, T. L., Crum, R. M., Cooper-Patrick, L., Ford, D., & Brancati, F. (2000). Depressive symptoms and metabolic control in African Americans with type 2 diabetes. Diabetes Care, 23, 23-29. PubMed doi:10.2337/diacare.23.1.23
8. Grossberg, R., Zhan, Y., & Gross, R. (2004). A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. Journal of Clinical Epidemiology, 57, 1107-1110. PubMed doi:10.1016/j.jclinepi.2004.04.002
9. Guénette, L., Moisan, J., Preville, M., & Boyer, R. (2005). Measures of adherence based on self-report exhibited poor agreement with those based on pharmacy records. Journal of Clinical Epidemiology, 58, 924-933. PubMed doi:10.1016/j.jclinepi.2005.02.002
10. Hertz, R. P., Unger, A. N., & Lustik, M. B. (2005). Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clinical Therapeutics, 27, 1064-1073. PubMed doi:10.1016/j.clinthera.2005.07.009
11. Hess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C. (2006). Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. The Annals of Pharmacotherapy, 40, 1280-1288. PubMed doi:10.1345/aph.1H018
12. Hope, C. J., Wu, J., Tu, W., Young, J., & Murray, M. D. (2004). Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. American Journal of Health-System Pharmacy, 61, 2043-2049. PubMed
13. Insull, W. (1997). The problem of compliance to cholesterol altering therapy. Journal of Internal Medicine, 241, 317-325. PubMed doi:10.1046/j.1365-2796.1997.112133000.x
14. Jin, J., Sklar, G. E., Min Sen Oh, V., & Chuen, L. S. (2008). Factors affecting therapeutic compliance: a review from the patient's perspective. Therapeutics and Clinical Risk Management, 4(1), 269-286. PubMed
15. Kardas, P. (2004). Comparison of once daily versus twice daily oral nitrates in stable angina pectoris. The American Journal of Cardiology, 94, 213-216. PubMed doi:10.1016/j.amjcard.2004.03.067
16. Kardas, P. (2007). Compliance, clinical outcome, and quality of life of patients with stable anginal pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial. Vascular Health and Risk Management, 3(2), 235-242. PubMed doi:10.2147/vhrm.2007.3.2.235
17. Kim, Y. S., Sunwoo, S., Lee, H. R., Lee, K. M., Park, Y. W., Shin, H. C.,. Huh, B. Y. (2002). Determinants of non-compliance with lipid-lowering therapy in hyperlipidemic patients. Pharmacoepidemiology and Drug Safety, 11, 593-600. PubMed doi:10.1002/pds.730
18. LaFleur, J., & Oderda, G. M. (2004). Methods to measure patient compliance with medication regimens. Journal of Pain & Palliative Care Pharmacotherapy, 18, 81-87. PubMed
19. Malhotra, S., Karan, R. S., Pandhi, P., & Jain, S. (2001). Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgraduate Medical Journal, 77, 703-707. PubMed doi:10.1136/pmj.77.913.703
20. Monane, M., Bohn, R. L., Gurwitz, J. H., Glynn, R. J., Levin, R., & Avorn, J. (1996). Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. American Journal of Public Health, 86, 1805-1808. PubMed doi:10.2105/AJPH.86.12.1805
21. Munger, M. A., Van Tassell, B. W., & LaFleur, J. (2007). Medication Nonadherence: an unrecognized cardiovascular risk factor. Medscape General Medicine, 9(3), 58. PubMed
22. Newby, L. K., LaPointe, N. M., Chen, A. Y., Kramer, J. M., Hammil, B. G., DeLong, E. R.,. Califf, R. M. (2006). Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation, 113, 203-212. PubMed doi:10.1161/CIRCULATIONAHA.105.505636
23. Obisesan, T. O., Vargas, M., & Gillum, R. (2000). Geographic variation in stroke risk in the United States: region, urbanization, and hypertension in the third national health and nutrition examination survey. Stroke, 31, 19-25. PubMed doi:10.1161/01.STR.31.1.19
24. Osterberg, L., & Blaschke, T. (2005). Adherence to medication. The New England Journal of Medicine, 353, 487-497. PubMed doi:10.1056/NEJMra050100
25. Raiz, L. R., Kilty, K. M., & Henry, M. L. (1999). Medication compliance following renal transplantation. Transplantation, 68, 51-55. PubMed doi:10.1097/00007890-199907150-00010
26. Research Data Assistance Center (ResDAC) (2010). Retrieved from http://www.resdac.umn.edu/ddvh/CMS_Part_D_Denominator_File_jul_2009.pdf.
27. Roter, D. L., Hall, J. A., Merisca, R., Nordstrom, B., Cretin, D., & Svarstad, B. (1998). Effectiveness of interventions to improve patient compliance. A meta-analysis. Medical Care, 36, 1138-1161. PubMed doi:10.1097/00005650-199808000-00004
28. Rudd, P. The measurement of compliance: medication taking. Developmental Aspects of Health Compliance Behavior. Krasnegor NA, Epstein L, Johnson SF, Yaffe SJ, Eds. Hillsdale, NJ, Lawrence Erlbaum Associates, 1993, p. 185-213.
29. SAS Institute, Inc. (2010), Reviewed September 20, 2010 from http://www.sas.com/
30. Schmittdiel, J. A., Ettner, S. L., Fung, V., Huang, J., Turk, N., Quiter, E.,. Mangoine, C. (2009) Medicare Part D coverage gap and diabetes beneficiaries. http://www.AMJC.com.;15(3),189-193
31. Senior, V., Marteau, T. M., & Weinman, J. (2004). Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: the role of illness perceptions. Cardiovascular Drugs and Therapy, 18, 475-481. PubMed doi:10.1007/s10557-004-6225-z
32. Sherman, B. W., Frazee, S. G., Fabius, R. J., Broome, R. A., Manfred, J. R., & Davis, J. C. (2009). Impact of workplace health services on adherence to chronic medications. The American Journal of Managed Care, 15(7), e53-e59. PubMed
33. Sirey, J. A., Bruce, M. L., Alexopoulos, G. S., Perlick, D. A., Friedman, S. J., & Meyers, B. S. (2001). Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatric Services (Washington, D.C.), 52, 1615-1620. PubMed doi:10.1176/appi.ps.52.12.1615
34. Skaer, T. L., Sclar, D. A., Markowski, D. J., & Won, J. K. H. (1993). Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures: a study of patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Pharmacy and Therapeutics, 18, 295-299. PubMed doi:10.1111/j.1365-2710.1993.tb00591.x
35. Sullivan, S. D., & Kreling, D. H. (1990). Noncompliance with medication regimens and subsequent hospitalizations: a literature analysis and cost of hospitalization estimate. Journal of Research in Pharmaceutical Economics, 2, 19-33.
36. Tangalos, E. G. & Zarowitz, B. J. (2006). Medication management in the elderly. Annals of Long Term Care., 14(8), 27-31.
37. Thomas, L. K., Sargent, R. G., Michels, P. C., Richter, D. L., Valois, R. F., & Moore, C. G. (2001). Identification of the factors associated with compliance to therapeutic diets in older adults with end stage renal disease. Journal of Renal Nutrition, 11, 80-89. PubMed doi:10.1016/S1051-2276(01)98615-7
38. U.S. Census Bureau (2010), Retrieved from http://www.census.gov/geo/www/us_regdiv.pdf
39. Vanderpoel, D. R., Hussein, M. A., Watson-Heidari, T., & Perry, A. (2004). Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis. Clinical Therapeutics, 26, 2066-2075. PubMed doi:10.1016/j.clinthera.2004.12.018
40. Wolters Kluwer Health, (2009). Master Drug Data Base. Retrieved from http://www.medispan.com/marketing/ContentPage.aspx?contentId=09e0f1ed-80a9-4a87-8bc9-ad778d7b6615
41. Weiden, P. J., Kozma, C., Grogg, A., & Locklear, J. (2004). Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services Washington, D.C.), 55, 886-891. PubMed doi:10.1176/appi.ps.55.8.886
42. Yanos, P. T. (2001). Characteristics and service use patterns of nonelderly Medicare beneficiaries with schizophrenia. Psychiatric Services (Washington, D.C.), 52, 1644-1650. PubMed doi:10.1176/appi.ps.52.12.1644
43. Yu, Y. F., Nicol, M. B., Yu, A. P., & Ahn, J. (2005). Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the California Medicaid program. Value in Health, 8, 495-505. PubMed doi:10.1111/j.1524-4733.2005.00041.x